» Articles » PMID: 32905923

Radiomics Analysis Using Stability Selection Supervised Component Analysis for Right-censored Survival Data

Overview
Journal Comput Biol Med
Publisher Elsevier
Date 2020 Sep 9
PMID 32905923
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Radiomics is a newly emerging field that involves the extraction of massive quantitative features from biomedical images by using data-characterization algorithms. Distinctive imaging features identified from biomedical images can be used for prognosis and therapeutic response prediction, and they can provide a noninvasive approach for personalized therapy. So far, many of the published radiomics studies utilize existing out of the box algorithms to identify the prognostic markers from biomedical images that are not specific to radiomics data. To better utilize biomedical images, we propose a novel machine learning approach, stability selection supervised principal component analysis (SSSuperPCA) that identifies stable features from radiomics big data coupled with dimension reduction for right-censored survival outcomes. The proposed approach allows us to identify a set of stable features that are highly associated with the survival outcomes in a simple yet meaningful manner, while controlling the per-family error rate. We evaluate the performance of SSSuperPCA using simulations and real data sets for non-small cell lung cancer and head and neck cancer, and compare it with other machine learning algorithms. The results demonstrate that our method has a competitive edge over other existing methods in identifying the prognostic markers from biomedical imaging data for the prediction of right-censored survival outcomes.

Citing Articles

aXonica: A support package for MRI based Neuroimaging.

Wajid B, Jamil M, Awan F, Anwar F, Anwar A Biotechnol Notes. 2024; 5:120-136.

PMID: 39416698 PMC: 11446389. DOI: 10.1016/j.biotno.2024.08.001.


Deep learning and machine learning predictive models for neurological function after interventional embolization of intracranial aneurysms.

Peng Y, Wang Y, Wen Z, Xiang H, Guo L, Su L Front Neurol. 2024; 15:1321923.

PMID: 38327618 PMC: 10848172. DOI: 10.3389/fneur.2024.1321923.


Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology RTOG 0617.

Lee S, Geng H, Arnold J, Caruana R, Fan Y, Rosen M Int J Radiat Oncol Biol Phys. 2023; 117(5):1270-1286.

PMID: 37343707 PMC: 10728350. DOI: 10.1016/j.ijrobp.2023.06.009.


Artificial intelligence-driven radiomics study in cancer: the role of feature engineering and modeling.

Zhang Y, Zhang X, Cheng Y, Li B, Teng X, Zhang J Mil Med Res. 2023; 10(1):22.

PMID: 37189155 PMC: 10186733. DOI: 10.1186/s40779-023-00458-8.


Predicting transient ischemic attack risk in patients with mild carotid stenosis using machine learning and CT radiomics.

Xia H, Yuan L, Zhao W, Zhang C, Zhao L, Hou J Front Neurol. 2023; 14:1105616.

PMID: 36846119 PMC: 9944715. DOI: 10.3389/fneur.2023.1105616.


References
1.
Huang Y, Liu Z, He L, Chen X, Pan D, Ma Z . Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer. Radiology. 2016; 281(3):947-957. DOI: 10.1148/radiol.2016152234. View

2.
Friedman J, Hastie T, Tibshirani R . Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010; 33(1):1-22. PMC: 2929880. View

3.
Mayr A, Hofner B, Schmid M . Boosting the discriminatory power of sparse survival models via optimization of the concordance index and stability selection. BMC Bioinformatics. 2016; 17:288. PMC: 4957316. DOI: 10.1186/s12859-016-1149-8. View

4.
Shaikh F, Kolowitz B, Awan O, Aerts H, von Reden A, Halabi S . Technical Challenges in the Clinical Application of Radiomics. JCO Clin Cancer Inform. 2019; 1:1-8. DOI: 10.1200/CCI.17.00004. View

5.
Kickingereder P, Gotz M, Muschelli J, Wick A, Neuberger U, Shinohara R . Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response. Clin Cancer Res. 2016; 22(23):5765-5771. PMC: 5503450. DOI: 10.1158/1078-0432.CCR-16-0702. View